13 July 2010

It's hard to overestimate the damage GSK has done to itself. They employ an academic hit man, hide negative data, ban employees from pharma gossip sites, improperly obtain articles before publication, and more. Read about it here: http://bit.ly/bT0eWn.

No comments: